Getting out of the Rough with Jason Day | AstraZeneca

A 6-part video series that highlights the importance of biomarker testing after a lung cancer diagnosis.

Overview

Getting Out of the Rough is a 6-part series hosted by PGA champion, Jason Day. The campaign brings awareness to biomarker testing information through Jason’s story as a caregiver to his mother who was diagnosed with stage IV non-small cell lung cancer. In each episode, Jason interviews an influencer from the fields of medicine or entertainment about their experience caring for a loved one with lung cancer. Celebrity guests include Julie Bowen, Anthony Anderson, and Bellamy Young.

Mobile screens

Website Design

In collaboration with the art director, we designed and prototyped the campaign website to host the episodes and supplemental resources for navigating a lung cancer diagnosis.

Mobile screens

Integrated Marketing

I was the lead designer for integrated marketing materials. We reached our audiences across numerous platforms, including animated and static display ads, organic and paid social graphics, Spotify ads, and a two-page advertorial in PGA Magazine.

PGA Magazine advertorial

Results

The goal of the campaign was to increase awareness of biomarker testing among lung cancer patients, caregivers, and healthcare providers. Launching in April 2022, the campaign was met with major success: 

82MM

social media impressions

301,000+

website visits

337%

 increase in monthly medical oncology patient visits

Social graphics

Awards

Ragan’s PR Daily Awards, Influencer Campaign Finalist
PM360 Trailblazer Awards, Unbranded Campaign Gold Winner
PRovoke Media North American SABRE Awards, Pharmaceutical: Rx Finalist

More work


Notes of EnCOURAGEment | AstraZeneca

An unbranded campaign to deliver encouraging messages by lung cancer patients to others in active treatment.

Brand Agent | People Inc.

People Inc’s agentic AI-powered ad unit that adapts to each user’s context in real time.

Rhythm Pharma Website Design

Rhythm Pharma is a biopharmaceutical company developing treatments for patients with rare neuroendocrine diseases.